A pharmaceutical composition, preparation and preparation method for treating epilepsy

Abstract

A pharmaceutical composition, preparation and preparation method for treating epilepsy, relating to the field of medical technology. A pharmaceutical composition for the treatment of epilepsy. The pharmaceutical composition includes, in parts by weight: 7-12 parts of dragon's teeth, 7-12 parts of calcined oyster, 7-12 parts of Jua Ming, 3 to 7 parts of antelope horn, and 12 parts of Gastrodia elata. -18 parts, 7-12 parts of Bombyx mori, 2-5 parts of cinnabar, 7-12 parts of amber, 7-12 parts of whole insect, 7-12 parts of centipede, 12-18 parts of Acorus, 7-12 parts of Tianzhu Huang, 3 to 7 parts of binan star, 7 to 12 parts of frankincense, 7 to 12 parts of myrrh, 1 to 3 parts of bezoar, 6 to 10 parts of tortoise shell, 0.2 to 0.5 parts of musk, and 5 to 10 parts of snake head. The pharmaceutical composition is formulated according to the theory of traditional Chinese medicine. The combined use of each component has the effects of clearing heat and reducing phlegm, removing blood stasis and unblocking collaterals, calming the liver and extinguishing wind, clearing the heart and calming the mind, and sedating epilepsy and relieving spasm. It has a very good therapeutic effect on epilepsy.

Description

technical field

[0001] The invention relates to the technical field of medicine, and in particular to a pharmaceutical composition, preparation and preparation method for treating epilepsy. Background technique

[0002] Epilepsy, commonly known as epilepsy, is a syndrome of chronic recurrent transient brain dysfunction. It is characterized by recurrent epileptic seizures caused by abnormal discharge of brain neurons. Epilepsy can be divided into primary and secondary according to the etiology. Primary means that the encephalopathy of such patients has no structural changes or metabolic abnormalities that can explain the symptoms, but has a close relationship with genetic factors. Secondary epilepsy is due to a variety of brain lesions and metabolic disorders, such as congenital diseases, prenatal and perinatal diseases (birth trauma is a common cause of epilepsy in infancy), sequelae of febrile convulsions, trauma, infection, poisoning , intracranial tumors, cerebrovascul...

Examples

preparation example Construction

[0040] A preparation method of a medicinal preparation for treating epilepsy, comprising: in parts by weight, dragon teeth, calcined oysters, cassia, antelope horns, Gastrodia elata, silkworm, cinnabar, amber, whole insects, centipedes, calamus, The powders of geranium yellow, gallinaceous star, frankincense, myrrh, bezoar, tortoise shell, musk and white snake head are mixed to obtain a powder. Wherein, the particle size of the powder is 10-50 μm.

[0041] Further, it also includes mixing the powder with pharmaceutically acceptable auxiliary materials, drying, and compressing into tablets to obtain pills or tablets. Or the powder is filled in capsules to obtain capsules. Wherein, the pharmaceutically acceptable auxiliary material can be xylitol or glucose. It should be noted that the pharmaceutically acceptable excipients are not limited to xylitol or glucose.

[0042] The preparation method of the pharmaceutical preparation is simple and easy to implement, and has strong o...

Embodiment 1

[0045]This embodiment provides a pharmaceutical preparation for treating epilepsy, which is obtained by grinding the pharmaceutical composition for treating epilepsy into powder and mixing. The pharmaceutical composition comprises: 7g of dragon teeth, 9g of calcined oysters, 10g of Cassia chinensis, 5g of antelope horns, 13g of Gastrodia elata, 8g of silkworms, 5g of cinnabar, 12g of amber, 9g of whole insects, 10g of centipedes, 14g of calamus, 10g of Tianzhuhuang , Dannanxing 4g, frankincense 10g, myrrh 8g, bezoar 1.8g, tortoise shell 8g, musk 0.3g and white snake head 7g.

Embodiment 2

[0047] This embodiment provides a pharmaceutical preparation for treating epilepsy, which is obtained by grinding the pharmaceutical composition for treating epilepsy into powder and mixing. The pharmaceutical composition comprises: 9g of dragon teeth, 8g of calcined oysters, 11g of Cassia chinensis, 6g of antelope horns, 12g of Gastrodia elata, 10g of silkworm, 3g of cinnabar, 8g of amber, 11g of whole insects, 7g of centipedes, 16g of calamus calamus, and 9g of Tianzhuhuang , Dannanxing 6g, frankincense 8g, myrrh 12g, bezoar 2g, tortoise shell 9g, musk 0.5g and white snake head 9g.

technical field

[0001] The invention relates to the technical field of medicine, and in particular to a pharmaceutical composition, preparation and preparation method for treating epilepsy. Background technique

[0002] Epilepsy, commonly known as epilepsy, is a syndrome of chronic recurrent transient brain dysfunction. It is characterized by recurrent epileptic seizures caused by abnormal discharge of brain neurons. Epilepsy can be divided into primary and secondary according to the etiology. Primary means that the encephalopathy of such patients has no structural changes or metabolic abnormalities that can explain the symptoms, but has a close relationship with genetic factors. Secondary epilepsy is due to a variety of brain lesions and metabolic disorders, such as congenital diseases, prenatal and perinatal diseases (birth trauma is a common cause of epilepsy in infancy), sequelae of febrile convulsions, trauma, infection, poisoning , intracranial tumors, cerebrovascul...

Examples

preparation example Construction

[0040] A preparation method of a medicinal preparation for treating epilepsy, comprising: in parts by weight, dragon teeth, calcined oysters, cassia, antelope horns, Gastrodia elata, silkworm, cinnabar, amber, whole insects, centipedes, calamus, The powders of geranium yellow, gallinaceous star, frankincense, myrrh, bezoar, tortoise shell, musk and white snake head are mixed to obtain a powder. Wherein, the particle size of the powder is 10-50 μm.

[0041] Further, it also includes mixing the powder with pharmaceutically acceptable auxiliary materials, drying, and compressing into tablets to obtain pills or tablets. Or the powder is filled in capsules to obtain capsules. Wherein, the pharmaceutically acceptable auxiliary material can be xylitol or glucose. It should be noted that the pharmaceutically acceptable excipients are not limited to xylitol or glucose.

[0042] The preparation method of the pharmaceutical preparation is simple and easy to implement, and has strong o...

Embodiment 1

[0045]This embodiment provides a pharmaceutical preparation for treating epilepsy, which is obtained by grinding the pharmaceutical composition for treating epilepsy into powder and mixing. The pharmaceutical composition comprises: 7g of dragon teeth, 9g of calcined oysters, 10g of Cassia chinensis, 5g of antelope horns, 13g of Gastrodia elata, 8g of silkworms, 5g of cinnabar, 12g of amber, 9g of whole insects, 10g of centipedes, 14g of calamus, 10g of Tianzhuhuang , Dannanxing 4g, frankincense 10g, myrrh 8g, bezoar 1.8g, tortoise shell 8g, musk 0.3g and white snake head 7g.

Embodiment 2

[0047] This embodiment provides a pharmaceutical preparation for treating epilepsy, which is obtained by grinding the pharmaceutical composition for treating epilepsy into powder and mixing. The pharmaceutical composition comprises: 9g of dragon teeth, 8g of calcined oysters, 11g of Cassia chinensis, 6g of antelope horns, 12g of Gastrodia elata, 10g of silkworm, 3g of cinnabar, 8g of amber, 11g of whole insects, 7g of centipedes, 16g of calamus calamus, and 9g of Tianzhuhuang , Dannanxing 6g, frankincense 8g, myrrh 12g, bezoar 2g, tortoise shell 9g, musk 0.5g and white snake head 9g.